INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress

Go back to INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962       

(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962